YoheiDoiMD
Infectious Disease • Pittsburgh, PAAssistant Professor, Medicine, University of Pittsburgh School of Medicine
Are you Dr. Doi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# Falk
Pittsburgh, PA 15213Phone+1 412-648-6401Fax+1 412-648-6399
Summary
- Dr. Yohei Doi, MD is an infectious disease specialist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with UPMC Presbyterian Shadyside and UPMC Magee-Womens Hospital.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2005 - 2008
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2003 - 2005
Nagoya University - School of MedicineClass of 1998
Certifications & Licensure
PA State Medical License 2005 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Gram Negative Bacteremia, Risk Factors for Failure of Therapy Start of enrollment: 2005 Apr 01
- Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria Start of enrollment: 2006 Jan 01
- Community - Associated Extended-spectrum Beta-lactamases (ESBL) Start of enrollment: 2006 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- The impact of infectious diseases department on the incidence of hospital-onset bacteremia and fungemia at a tertiary care center: a retrospective cohort study.Yuya Kawamoto, Akane Takamatsu, Kenjiro Matsui, Yohei Doi, Hitoshi Honda
Infection Control and Hospital Epidemiology. 2025-02-14 - Clinical and microbiological characteristics of skin and soft tissue infections of the extremities with bacteremia in patients with malignancy.Taisuke Enokida, Sohei Harada, Koh Okamoto, Daisuke Ohkushi, Koichi Takeda
Journal of Infection and Chemotherapy. 2025-02-07 - Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients.Eiki Ogawa, Masahiro Suzuki, Aki Sakurai, Yohei Doi
Journal of the Pediatric Infectious Diseases Society. 2025-02-04
Press Mentions
Fujita Health University Favipiravir Trial Evidences No Statistically Conclusive Benefit to COVID-19 Patients: A Question Mark for Favipiravir?July 11th, 2020- WHO Studies File International Each Day Coronavirus Circumstances Improve: LiveJuly 10th, 2020
No Pause in Coronavirus Trial for Avigan, Japan's Lead Researcher SaysMay 20th, 2020- Join now to see all
Grant Support
- Multidrug-Resistant Acinetobacter BaumanniiNational Institute Of Allergy And Infectious Diseases2009–2010
- Epidemiology Of Community-Associated, Esbl-Producing Escherichia ColiNational Institute Of Allergy And Infectious Diseases2009–2010
Professional Memberships
- Member
